Literature DB >> 26960970

CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome.

Aysel Ahadova1,2,3,4, Magnus von Knebel Doeberitz1,2,3,4, Hendrik Bläker5, Matthias Kloor6,7,8,9.   

Abstract

The implementation of regular colonoscopy programs has significantly decreased the mortality associated with colorectal cancer (CRC) in Lynch syndrome patients. However, interval CRCs in Lynch syndrome that remain undetected by colonoscopy still represent a substantial problem in the management of the syndrome. One possible reason of interval cancers could be a non-polypous pathway of cancer development. To examine the possibility of a non-polypous pathway of CRC development in Lynch syndrome, we analyzed the histological appearance of 46 Lynch syndrome-associated CRCs and compared them to 34 sporadic microsatellite unstable cancers. We observed that 25 (62.5 %) out of 40 assessable Lynch syndrome-associated carcinomas lacked evidence of polypous growth, compared to 17 (50 %) out of 34 sporadic MSI-H cancers. We detected CTNNB1 mutations in 8 (17.4 %) out of 46 Lynch syndrome-associated cancers compared to 0 out of 34 sporadic MSI-H cancers (p = 0.01). The majority of CTNNB1-mutant cancers presented with a histological appearance suggesting immediate invasive growth. Our results suggest that a distinct subgroup of CRCs in Lynch syndrome may in fact emerge from a non-polypous precursor, thus potentially explaining the phenomenon of interval cancers. Such a non-polypous precursor may be the recently described mismatch repair-deficient crypt focus, which remains invisible for the examiner during colonoscopy. This calls for considering the implementation of active, primary preventive measures in the management of Lynch syndrome. Future studies on pathogenic pathways and precursor lesions in Lynch syndrome are strongly encouraged, and the clinical efficacy of new prevention approaches should be evaluated in prospective clinical trials.

Entities:  

Keywords:  Interval cancer; Lynch syndrome; Microsatellite instability; Mismatch repair deficiency; Mismatch repair deficient crypt focus; β-catenin

Mesh:

Substances:

Year:  2016        PMID: 26960970     DOI: 10.1007/s10689-016-9899-z

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  32 in total

Review 1.  Molecular tests for colorectal cancer screening.

Authors:  Linda J W Bosch; Beatriz Carvalho; Remond J A Fijneman; Connie R Jimenez; Herbert M Pinedo; Manon van Engeland; Gerrit A Meijer
Journal:  Clin Colorectal Cancer       Date:  2011-03-01       Impact factor: 4.481

Review 2.  Stool Testing for Colorectal Cancer Screening.

Authors:  Douglas J Robertson; Thomas F Imperiale
Journal:  Gastroenterology       Date:  2015-05-30       Impact factor: 22.682

3.  Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families.

Authors:  Wouter H de Vos tot Nederveen Cappel; Fokko M Nagengast; Gerrit Griffioen; Fred H Menko; Babs G Taal; Jan H Kleibeuker; Hans F Vasen
Journal:  Dis Colon Rectum       Date:  2002-12       Impact factor: 4.585

4.  Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.

Authors:  Heather Hampel; Julie A Stephens; Eero Pukkala; Risto Sankila; Lauri A Aaltonen; Jukka-Pekka Mecklin; Albert de la Chapelle
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

5.  Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment.

Authors:  F Quehenberger; H F A Vasen; H C van Houwelingen
Journal:  J Med Genet       Date:  2005-06       Impact factor: 6.318

6.  Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.

Authors:  Matthias Kloor; Cathrin Huth; Anita Y Voigt; Axel Benner; Peter Schirmacher; Magnus von Knebel Doeberitz; Hendrik Bläker
Journal:  Lancet Oncol       Date:  2012-05-01       Impact factor: 41.316

7.  Association of the APC tumor suppressor protein with catenins.

Authors:  L K Su; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1993-12-10       Impact factor: 47.728

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Authors:  John Burn; Anne-Marie Gerdes; Finlay Macrae; Jukka-Pekka Mecklin; Gabriela Moeslein; Sylviane Olschwang; Diane Eccles; D Gareth Evans; Eamonn R Maher; Lucio Bertario; Marie-Luise Bisgaard; Malcolm G Dunlop; Judy W C Ho; Shirley V Hodgson; Annika Lindblom; Jan Lubinski; Patrick J Morrison; Victoria Murday; Raj Ramesar; Lucy Side; Rodney J Scott; Huw J W Thomas; Hans F Vasen; Gail Barker; Gillian Crawford; Faye Elliott; Mohammad Movahedi; Kirsi Pylvanainen; Juul T Wijnen; Riccardo Fodde; Henry T Lynch; John C Mathers; D Timothy Bishop
Journal:  Lancet       Date:  2011-10-27       Impact factor: 79.321

10.  Nuclear beta-catenin expression is closely related to ulcerative growth of colorectal carcinoma.

Authors:  J M Chiang; Y H Wu Chou; T C Chen; K F Ng; J L Lin
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

View more
  19 in total

Review 1.  Recent advances in Lynch syndrome.

Authors:  Leah H Biller; Sapna Syngal; Matthew B Yurgelun
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

2.  RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.

Authors:  Lochlan J Fennell; Mark Clendenning; Diane M McKeone; Saara H Jamieson; Samanthy Balachandran; Jennifer Borowsky; John Liu; Futoshi Kawamata; Catherine E Bond; Christophe Rosty; Matthew E Burge; Daniel D Buchanan; Barbara A Leggett; Vicki L J Whitehall
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

Review 3.  Recent progress in Lynch syndrome and other familial colorectal cancer syndromes.

Authors:  Patrick M Boland; Matthew B Yurgelun; C Richard Boland
Journal:  CA Cancer J Clin       Date:  2018-02-27       Impact factor: 508.702

4.  Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR-Deficient Colorectal Cancer.

Authors:  Ibrahim Halil Sahin; Subir Goyal; Yoanna Pumpalova; Mohamad B Sonbol; Satya Das; Sigurdis Haraldsdottir; Daniel Ahn; Kristen K Ciombor; Zhengjia Chen; Amber Draper; Jordan Berlin; Tanios Bekaii-Saab; Gregory B Lesinski; Bassel F El-Rayes; Christina Wu
Journal:  Oncologist       Date:  2021-03-22

Review 5.  Progress Report: New insights into the prevention of CRC by colonoscopic surveillance in Lynch syndrome.

Authors:  Hans F A Vasen
Journal:  Fam Cancer       Date:  2021-01-19       Impact factor: 2.375

Review 6.  Discovering the Mutational Profile of Early Colorectal Lesions: A Translational Impact.

Authors:  Chiara Alquati; Anna Prossomariti; Giulia Piazzi; Francesco Buttitta; Franco Bazzoli; Luigi Laghi; Luigi Ricciardiello
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

7.  Characterizing Microsatellite Instability and Chromosome Instability in Interval Colorectal Cancers.

Authors:  Amy L Cisyk; Zoann Nugent; Robert H Wightman; Harminder Singh; Kirk J McManus
Journal:  Neoplasia       Date:  2018-08-15       Impact factor: 5.715

Review 8.  Targeting Wnt Signaling in Endometrial Cancer.

Authors:  Iram Fatima; Susmita Barman; Rajani Rai; Kristina W W Thiel; Vishal Chandra
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

9.  No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study.

Authors:  Mev Dominguez-Valentin; John-Paul Plazzer; Julian R Sampson; Christoph Engel; Stefan Aretz; Mark A Jenkins; Lone Sunde; Inge Bernstein; Gabriel Capella; Francesc Balaguer; Finlay Macrae; Ingrid M Winship; Huw Thomas; Dafydd Gareth Evans; John Burn; Marc Greenblatt; Wouter H de Vos Tot Nederveen Cappel; Rolf H Sijmons; Maartje Nielsen; Lucio Bertario; Bernardo Bonanni; Maria Grazia Tibiletti; Giulia Martina Cavestro; Annika Lindblom; Adriana Della Valle; Francisco Lopez-Kostner; Karin Alvarez; Nathan Gluck; Lior Katz; Karl Heinimann; Carlos A Vaccaro; Sigve Nakken; Eivind Hovig; Kate Green; Fiona Lalloo; James Hill; Hans F A Vasen; Claudia Perne; Reinhard Büttner; Heike Görgens; Elke Holinski-Feder; Monika Morak; Stefanie Holzapfel; Robert Hüneburg; Magnus von Knebel Doeberitz; Markus Loeffler; Nils Rahner; Jürgen Weitz; Verena Steinke-Lange; Wolff Schmiegel; Deepak Vangala; Emma J Crosbie; Marta Pineda; Matilde Navarro; Joan Brunet; Leticia Moreira; Ariadna Sánchez; Miquel Serra-Burriel; Miriam Mints; Revital Kariv; Guy Rosner; Tamara Alejandra Piñero; Walter Hernán Pavicic; Pablo Kalfayan; Sanne W Ten Broeke; Jukka-Pekka Mecklin; Kirsi Pylvänäinen; Laura Renkonen-Sinisalo; Anna Lepistö; Päivi Peltomäki; John L Hopper; Aung Ko Win; Daniel D Buchanan; Noralane M Lindor; Steven Gallinger; Loïc Le Marchand; Polly A Newcomb; Jane C Figueiredo; Stephen N Thibodeau; Christina Therkildsen; Thomas V O Hansen; Lars Lindberg; Einar Andreas Rødland; Florencia Neffa; Patricia Esperon; Douglas Tjandra; Gabriela Möslein; Toni T Seppälä; Pål Møller
Journal:  J Clin Med       Date:  2021-06-28       Impact factor: 4.241

10.  Features of incident colorectal cancer in Lynch syndrome.

Authors:  Tanja E Argillander; Jan J Koornstra; Mariette van Kouwen; Alexandra Mj Langers; Fokko M Nagengast; Juda Vecht; Wouter H de Vos Tot Nederveen Cappel; Evelien Dekker; Peter van Duijvendijk; Hans Fa Vasen
Journal:  United European Gastroenterol J       Date:  2018-06-11       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.